April D. Thames|Jennifer Moizel|Stella E. Panos|Srushti Patel|Desiree Byrd|Héctor F. Myers|Gail E. Wyatt|Charles H. Hinkin
Differential Predictors of Medication Adherence in HIV: Findings from a Sample of African American and Caucasian HIV-Positive Drug-Using Adults
Neurobehavioral Systems|University of California, Los Angeles|VA Greater Los Angeles Healthcare System|Alliant International University|Neurobehavioral Systems|University of California, Los Angeles|VA Greater Los Angeles Healthcare System|Neurobehavioral Systems|University of California, Los Angeles|VA Greater Los Angeles Healthcare System|Icahn School of Medicine at Mount Sinai|Neurobehavioral Systems|University of California, Los Angeles|Neurobehavioral Systems|University of California, Los Angeles|Neurobehavioral Systems|University of California, Los Angeles|VA Greater Los Angeles Healthcare System
modest even occasional nonadherence combined antiretroviral therapy cart result adverse clinical outcomes african americans demonstrate lower rates adherence caucasians latinos identifying factors influence medication adherence among african americans critical step toward reducing hivaids disease progression mortality sample 181 african american n144 caucasian n37 hivpositive drugusing individuals age m4231 sd66 education m1341 sd21 examined influence baseline drug use literacy neurocognition depression treatmentspecific social support patient satisfaction health care provider medication adherence averaged course 6 months study dates 20022006 findings suggest differential baseline predictors medication adherence african americans caucasians patient satisfaction provider strongest predictor followup medication adherence african americans whereas caucasians depressive symptoms treatmentspecific social support predictive medication adherence controlling duration drug use